+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID03024671

Skin Compatibility Testing of Cosmetic Products Using Patch Tests for Dermatitis Diagnosis

Led by Insel Gruppe AG, University Hospital Bern · Updated on 2024-11-19

180

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are studying the skin compatibility of cosmetic products by testing for potential irritants and allergic reactions. This trial focuses on adults with skin conditions who undergo patch testing to identify whether cosmetics cause skin irritation or allergies. The study is led by Insel Gruppe AG, University Hospital Bern, and aims to assess the safety of new or reformulated cosmetics for people with dermatitis. Participants will receive a patch test where a cosmetic product is applied to their back to observe skin reactions. This procedure helps to detect allergic or irritant responses. The study does not use a control or placebo group and does not involve masking or blinding. During the study, participants will be monitored for positive skin reactions to the patch test over a period of four weeks. Researchers will track the number of patients showing allergic or irritant responses. Participants must avoid certain medications and skin treatments before testing and will be followed to ensure accurate results and safety throughout the trial.

CONDITIONS

Brief Title

Epicutaneous Testing of Cosmetics for Skin Compatibility

Research Team

D

Dagmar Simon, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here